Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study for Identification of Predictive Immune Biomarker for Atezolizumab Therapy in NSCLC Patients

NCT04312308 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT04312308
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04312308 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study for Identification of Predictive Immune Biomarker for Atezolizumab Therapy in NSCLC Patients
Lead sponsor
Yonsei University
Phase
Observational
Overall status
Completed
Start date
April 8, 2020
Completion date
January 26, 2025
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer